These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 9151912)
1. Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study. Ono T; Nagasue N; Kohno H; Hayashi T; Uchida M; Yukaya H; Yamanoi A Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-18-S6-25. PubMed ID: 9151912 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials. Ono T; Yamanoi A; Nazmy El Assal O; Kohno H; Nagasue N Cancer; 2001 Jun; 91(12):2378-85. PubMed ID: 11413528 [TBL] [Abstract][Full Text] [Related]
3. Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma. Huang YH; Wu JC; Lui WY; Chau GY; Tsay SH; Chiang JH; King KL; Huo TI; Chang FY; Lee SD World J Surg; 2000 May; 24(5):551-5. PubMed ID: 10787075 [TBL] [Abstract][Full Text] [Related]
4. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Takenaka K; Yoshida K; Nishizaki T; Korenaga D; Hiroshige K; Ikeda T; Sugimachi K Am J Surg; 1995 Apr; 169(4):400-4; discussion 405. PubMed ID: 7694977 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study. Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237 [TBL] [Abstract][Full Text] [Related]
6. Postoperative adjuvant chemotherapy after radical hepatic resection for hepatocellular carcinoma (HCC). Kohno H; Nagasue N; Hayashi T; Yamanoi A; Uchida M; Ono T; Yukaya H; Kimura N; Nakamura T Hepatogastroenterology; 1996; 43(12):1405-9. PubMed ID: 8975939 [TBL] [Abstract][Full Text] [Related]
7. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma. Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment. Hsiao JH; Tsai CC; Liang TJ; Chiang CL; Liang HL; Chen IS; Chen YC; Chang PM; Chou NH; Wang BW Int J Surg; 2017 Sep; 45():35-41. PubMed ID: 28728985 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant hepatic arterial infusional chemotherapy with 5-fluorouracil and cisplatin after curative resection of hepatocellular carcinoma. Kim DY; Ahn SH; Kim SU; Choi SB; Lee KH; Park MS; Park JY; Lee DY; Han KH; Kim KS Oncology; 2011; 81(3-4):184-91. PubMed ID: 22067673 [TBL] [Abstract][Full Text] [Related]
10. [Postoperative adjuvant arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma]. Nakashima K; Aramaki M; Kawano K; Yoshida T; Kim YI; Kitano S; Kobayashi M Gan To Kagaku Ryoho; 1995 Sep; 22(11):1483-5. PubMed ID: 7574738 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis. Wen J; Shen WL; Yang SH Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580 [TBL] [Abstract][Full Text] [Related]
12. [Efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin-C]. Hwang JY; Jang BK; Kwon KM; Chung WJ; Park KS; Cho KB; Hwang JS; Ahn SH; Kim GC; Kim YH; Choi JS; Kwon JH Korean J Gastroenterol; 2005 Feb; 45(2):118-24. PubMed ID: 15725716 [TBL] [Abstract][Full Text] [Related]
13. Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial. Ishizuka M; Kubota K; Nemoto T; Shimoda M; Kato M; Iso Y; Tago K Asian J Surg; 2016 Jul; 39(3):149-54. PubMed ID: 26123137 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Olthoff KM; Rosove MH; Shackleton CR; Imagawa DK; Farmer DG; Northcross P; Pakrasi AL; Martin P; Goldstein LI; Shaked A Ann Surg; 1995 Jun; 221(6):734-41; discussion 731-43. PubMed ID: 7794077 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma. Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823 [TBL] [Abstract][Full Text] [Related]
16. Combination adjuvant chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin after liver transplantation for hepatocellular carcinoma: a preliminary open-label study. Zhang Q; Chen H; Li Q; Zang Y; Chen X; Zou W; Wang L; Shen ZY Invest New Drugs; 2011 Dec; 29(6):1360-9. PubMed ID: 21809025 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma. Yamamoto M; Arii S; Sugahara K; Tobe T Br J Surg; 1996 Mar; 83(3):336-40. PubMed ID: 8665186 [TBL] [Abstract][Full Text] [Related]
18. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study. Chau GY; Lui WY; Tsay SH; Chao Y; King KL; Wu CW Ann Surg Oncol; 2006 Oct; 13(10):1329-37. PubMed ID: 16897271 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial. Xia Y; Qiu Y; Li J; Shi L; Wang K; Xi T; Shen F; Yan Z; Wu M Ann Surg Oncol; 2010 Dec; 17(12):3137-44. PubMed ID: 20602260 [TBL] [Abstract][Full Text] [Related]
20. Transarterial infusion chemotherapy with epirubicin in water-in-oil-in-water emulsion for recurrent hepatocellular carcinoma in the residual liver after hepatectomy. Ikushima I; Higashi S; Seguchi K; Ishii A; Ota Y; Shima M; Kanemaru M; Hidaka Y Eur J Radiol; 2009 Jan; 69(1):114-9. PubMed ID: 17935921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]